Oncotelic Therapeutics, Inc. (OTLC)
Data as of , from SEC Form 4 filings.
See up to 3 months of OTLC. The 7-day demo opens the 1M and 3M ranges and puts OTLC on your watchlist.
Start 7-day demoLatest OTLC insider trades
About Oncotelic Therapeutics, Inc. (OTLC)
OTLC Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 1,356,990 | $24K |
OTLC insider transactions (Form 4)
2115 Form 4 filings on record, the earliest from Nov 26, 2024, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Vuong Trieu - Officer | Open-market purchase | Common Stock | 1,044,990 | $0.02 | $18K | |
| Vuong Trieu - Officer | Open-market purchase | Common Stock | 312,000 | $0.02 | $6K | |
| Seymour Howard Fein - Officer | Grant or award | Restricted stock Units | 250 | $0.00 | - | |
 Steven W. King - Director | Grant or award | Restricted stock Units | 250 | $0.00 | - | |
 Anthony E. Maida III - Officer | Grant or award | Restricted stock Units | 1,500 | $0.00 | - | |
 Saran Saund - Officer | Grant or award | Restricted stock Units | 1,500 | $0.00 | - | |
| Amit B. Shah - Officer | Grant or award | Restricted stock Units | 1,500 | $0.00 | - | |
| Vuong Trieu - Officer | Grant or award | Restricted stock Units | 2,000 | $0.00 | - | |
| Vuong Trieu - Officer | Open-market purchase | Common Stock | 240,000 | $0.04 | $10K | |
| Vuong Trieu - Officer | Open-market purchase | Common Stock | 115,000 | $0.05 | $5K | |
| Vuong Trieu - Officer | Open-market purchase | Common Stock | 75,000 | $0.05 | $3K | |
| Vuong Trieu - Officer | Open-market purchase | Common Stock | 65,000 | $0.05 | $3K | |
| Amit B. Shah - Officer | Open-market purchase | Common Stock | 20,000 | $0.05 | $1K | |
| Vuong Trieu - Officer | Open-market purchase | Common Stock | 96,000 | $0.05 | $4K | |
| Vuong Trieu - Officer | Open-market purchase | Common Stock | 239,759 | $0.04 | $11K | |
| Vuong Trieu - Officer | Grant or award | Series A Convertible Preferred Stock | 4,426 | $0.00 footnote F2 | - | |
| ||||||
| Vuong Trieu - Officer | Grant or award | Series A Convertible Preferred Stock | 4,065 | $0.00 footnote F2 | - | |
| ||||||
| Vuong Trieu - Officer | Open-market purchase | Common Stock | 104,000 | $0.01 | $520 | |
| Vuong Trieu - Officer | Open-market purchase | Common Stock | 1 | $0.01 | - | |
| Vuong Trieu - Officer | Open-market purchase | Common Stock | 94,736 | $0.01 | $474 | |
| Vuong Trieu - Officer | Open-market purchase | Common Stock | 298,499 | $0.03 | $9K | |
OTLC insider trading FAQ
What is the latest insider trade for OTLC?
Oncotelic Therapeutics, Inc. (OTLC) had 1 insider filing in the last 90 days, with the most recent on 30 October 2026. The full record for OTLC runs to 15 Form 4 filings, the earliest from 26 November 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying OTLC stock?
2 insider purchases of OTLC were filed in the last 90 days, totaling $24K.
How many insiders are selling OTLC stock?
No insider sales of OTLC were filed in the last 90 days.
Where can I see OTLC SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects OTLC Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Vuong Trieu view on EDGAR
- - Seymour Howard Fein view on EDGAR
- - Steven W. King view on EDGAR
- - Anthony E. Maida III view on EDGAR
- - Saran Saund view on EDGAR
- - Amit B. Shah view on EDGAR
- - Vuong Trieu view on EDGAR
- - Vuong Trieu view on EDGAR
- - Vuong Trieu view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where OTLC's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow OTLC with a 7-day demo
- OTLC on your watchlist
- Every OTLC Form 4 filing on record
- Up to 3 months of OTLC price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
